Skip to main content
. Author manuscript; available in PMC: 2024 May 2.
Published in final edited form as: Cell Metab. 2023 Apr 20;35(5):855–874.e5. doi: 10.1016/j.cmet.2023.03.022

Table 1.

Clinical features of EAE after prophylactic treatment of Bezafibrate

Group # Sick/total (incidence) Maximum clinical score Cumulative disease index Mean weight on peak day
Vehicle 13/13 (100%) 3.9 ± 0.2 39.5 ± 2.1 21.0 ± 0.7
Bezafibrate 10/10 (100%) 2.6 ± 0.2 *** 22.0 ± 2.8**** 21.1 ± 0.7

Values shown are mean ± SEM; n =13 or 10 per group.

***

p< 0.001,

****

p< 0.0001 vs. vehicle group

Cumulative disease index: sum of clinical score of the entire period.